S-1 plus cisplatin chemotherapy with concurrent radiation for thymic basaloid carcinoma.
Tagawa
Tetsuzo
T
Department of Surgery, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors hospital, Hiroshima, Japan. tetagawa@yahoo.co.jp
Ohta
Mitsuhiko
M
Kuwata
Taiji
T
Awaya
Hirokazu
H
Ishida
Teruyoshi
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000473:pathology / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary / Q000628:therapy*; D008875:Middle Aged; D010094:Oxonic Acid / Q000008:administration & dosage; D011879:Radiotherapy Dosage; D016879:Salvage Therapy; D005641:Tegafur / Q000008:administration & dosage; D013934:Thymectomy; D013953:Thymus Neoplasms / Q000473:pathology / Q000628:therapy*
D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D002945:Cisplatin